AKT-IN-27
AKT-IN-27 (4a) is a potential anticancer drug that functions by selectively targeting Akt-driven signaling pathways. It induces apoptosis by activating caspase-3, causing G2/M phase cell cycle arrest, and disrupting mitochondrial membrane potential. AKT-IN-27 (4a) is applicable in research on triple-negative breast cancer (TNBC) .
Product Specifications
Field of Research
Cell Biology, Signal Transduction
Smiles
O=C (C1=C2SC (NC3=CC=CC=C3) =C1C (OCC) =O) C4=CC=CC=C4C2=O
Molecular Formula
C21H15NO4S
Molecular Weight
377.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV661446 1.0 µg DNA
CDC5L Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)
Sign In for Pricing
View Details 
LV666745 1.0 µg DNA
CACNG4 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 